SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM 8-K ...
Ampio Pharmaceuticals, Inc. 5445 DTC Parkway, P4 Greenwood Village, Colorado 80111 January 6, 2011 VIA EDGAR United States Securities...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ...
Table of Contents As filed with the Securities and Exchange Commission on November 12, 2010...
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant...
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) ...
CORRECTED: Ampio Pharmaceuticals Announces Completion of Negotiations for Acquisition of DMI BioSciences, Inc. PR Newswire GREENWOOD VILLAGE...
Ampio Pharmaceuticals, Inc. Announces Acquisition of DMI BioSciences, Inc. PR Newswire GREENWOOD VILLAGE, Colo., July 27 GREENWOOD VILLAGE...
Ampio Pharmaceuticals Announces Initiation of Phase II Clinical Trial of Optina™ PR Newswire GREENWOOD VILLAGE, Colo., July 21 GREENWOOD VILLAGE...
Ampio Pharmaceuticals, Inc. Appoints New Chairman and Chief Financial Officer PR Newswire GREENWOOD VILLAGE, Colo., May 10 GREENWOOD VILLAGE...
Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc. PR Newswire GREENWOOD VILLAGE, Colo., April 22 GREENWOOD VILLAGE, Colo., April 22...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.